Author

M. Razaq

Observed name: M.A. Razaq

Institution: OU Health Stephenson Cancer Center

Observed institutions: OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center

OpenAlex ID: A5108564794

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

2023 · B. Besse, E. Felip, et al. · Annals of Oncology · 80

910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

2020 · E.E. Cohen, R.L. Ferris, et al. · Annals of Oncology · 43

Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

2018 · A.L. Ho, N. Chau, et al. · Annals of Oncology · 24

A Phase 2a, Multicenter, Open-Label Study of RM-1929 Photoimmunotherapy in Patients With Recurrent Head And Neck Cancer

2018 · D. Cognetti, J.M. Curry, et al. · International Journal of Radiation Oncology*Biology*Physics · 9

A phase 1, multicenter, open-label, dose-escalation, combination study of RM-1929 and photoimmunotherapy in patients with recurrent head and neck cancer

2017 · S.T. Kochuparambil, D. McDonald, et al. · Annals of Oncology · 8

NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx

2018 · A. Trotti, J. Harris, et al. · International Journal of Radiation Oncology*Biology*Physics · 6

Integrated data review evaluating safety, pharmacokinetics (PK) and immunogenicity of RM-1929 photoimmunotherapy (PIT) in subjects with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC)

2019 · J.M. Johnson, D.M. Cognetti, et al. · Annals of Oncology · 4

Survival Following Photoimmunotherapy in Patients (Pts) with Recurrent Head and Neck Squamous Cell Carcinoma (rHNSCC)

2020 · A.M. Gillenwater, J.M. Johnson, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

Merkel Cell Carcinoma (MCC): Treatment and Outcomes Over the Past Ten Years at a High-Volume Academic Center

2019 · A. Mohammad-Zadeh, M.A. Razaq, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Abstract IA20: Radiotherapy plus cetuximab or cisplatin in human papilloma-virus positive oropharyngeal cancer (NRG 1016): A randomized multicenter noninferiority trial*

2020 · J.A. Ridge, J. Ringash, et al. · Clinical Cancer Research

P2.01-83 Role of Exosomal MicroRNAs (miRNAs) as Predictors of Response to Treatment and Prognosis in Non-Small Cell Lung Cancer (NSCLC)

2019 · M. Razaq, V. Pareek, et al. · Journal of Thoracic Oncology

Effect of nab-paclitaxel/carboplatin (nab-P/C) induction therapy on quality of life (QoL) of patients with squamous (SCC) non-small cell lung cancer (NSCLC) (ABOUND.sqm)

2017 · S. Ponce Aix, V. Villaflor, et al. · Annals of Oncology

Works count: 13

Citation count: 257

H-index: 6

I10-index: 4